Peripartum management of deep venous thrombosis in the context of antithrombin deficiency and May-Thurner syndrome

Blood Coagul Fibrinolysis. 2023 Apr 1;34(3):211-214. doi: 10.1097/MBC.0000000000001183. Epub 2022 Dec 28.

Abstract

Literature regarding the management of thrombus refractory to first-line treatment in the setting of pregnancy is limited, and management is made even more complicated in the context of thrombophilia. This case reviews the management of a patient with antithrombin deficiency who developed a massive thrombus during pregnancy, which was complicated by May-Thurner syndrome, lack of improvement with heparin, and preterm labor. The patient received multidisciplinary care throughout the pregnancy. At 35 weeks, anticoagulation was paused as she underwent induction of labor and delivery followed by postpartum placement of inferior vena cava filter and restarting heparin. Successful management of our pregnant patient with thrombus refractory to heparin hinged on individualized treatment for medical optimization with anticoagulation and antithrombin concentrate prior to labor followed by immediate postpartum placement of inferior vena cava filter.

MeSH terms

  • Anticoagulants / therapeutic use
  • Antithrombin III Deficiency* / complications
  • Antithrombin III Deficiency* / drug therapy
  • Antithrombins
  • Female
  • Heparin / therapeutic use
  • Humans
  • Infant, Newborn
  • May-Thurner Syndrome* / complications
  • Peripartum Period
  • Pregnancy
  • Vena Cava Filters* / adverse effects
  • Vena Cava, Inferior
  • Venous Thrombosis* / complications
  • Venous Thrombosis* / drug therapy

Substances

  • Heparin
  • Anticoagulants
  • Antithrombins